NIH Pulls Funding for Prospective Trial Exploring CV Effects of Moderate Alcohol Intake. Steve Stiles. June 20, 2018.

The National Institute on Aging has awarded a $2.2 million grant to investigators from Cleveland Clinic and The MetroHealth System to develop a new CV risk calculator that includes information ...

> Astellas Pharma has taken its $1 billion cash bid for CV Therapeutics directly to its target's shareholders, with a tender offer expected to be launched today. Astellas report ...